AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair

Last updated: November 26, 2024
Sponsor: Medtronic - MITG
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pentalogy Of Cantrell

Hernia

Treatment

MaxTack™ Motorized Fixation Device

Clinical Study ID

NCT06710795
MDT23014
  • Ages > 18
  • All Genders

Study Summary

Medtronic is sponsoring and funding the AFFIX study, a prospective, post-market, multicenter, nonrandomized, single-arm, interventional clinical study. The purpose of this study is to evaluate the performance and safety of the MaxTack™ Motorized Fixation Device when used for fixation of prosthetic material to soft tissue in minimally invasive ventral hernia repair procedures.

Eligibility Criteria

Inclusion

Preoperative Inclusion Criteria:

  1. Subject has provided informed consent (IC)

  2. Subject is 18 years of age or older at the time of consent

  3. Subject is able and willing to comply with the study requirements and follow-upschedule

  4. Subject is undergoing an elective, single-stage, primary or incisional ventralhernia repair

  5. Subject is undergoing minimally invasive ventral hernia repair procedure using theMaxTack™ Motorized Fixation Device

  6. Subject is undergoing minimally invasive ventral hernia repair procedure using aMedtronic (including Covidien) mesh that is intended to be used in compliance withthe mesh Instructions for Use (IFU)

  7. Subject is expected to meet the criteria for a class I wound (clean) as defined byCenters for Disease Control and Prevention (CDC) classification

Exclusion

Preoperative Exclusion Criteria:

  1. Subject is undergoing an emergency surgery (e.g., lifesaving procedures performedwhere subject is in imminent danger of death, strangulated hernia, etc.)

  2. Subject has history of 3 or more hernia repair procedures

  3. Subject has existing mesh in the space where the physician needs to apply the newmesh to be fixated with the MaxTack™ Motorized Fixation Device

  4. Subject is scheduled (or anticipated to be scheduled) for additional surgery, andsubsequent surgery would jeopardize previous application of study treatment

  5. Subject has history of allergic reactions to Poly (Glycolide-co-L-lActide) (PGLA)

  6. Subject has history of allergic reactions to the components of the intended mesh

  7. Subject has any systemic or local ongoing infection at the time of the surgery

  8. Subject has a Body Mass Index (BMI) greater than 45 kg/m2

  9. Subject has life expectancy in the opinion of the investigator, of less than 3 yearsat the time of enrollment

  10. Subject is pregnant (as determined by standard site practices) or is planning tobecome pregnant during study duration period.

  11. Subject has participated or will participate in an investigational drug or deviceresearch study that would interfere with the results of this study

  12. Subject's participation in the study may jeopardize the safety or welfare of thesubject, as determined by the investigator

  13. Subject is already enrolled or was previously enrolled in this study

Intraoperative Exclusion Criteria:

  1. Subject did not receive the MaxTack™ Motorized Fixation Device tacks to fixate themesh

  2. Subject did not receive a Medtronic (including Covidien) mesh

  3. Inability to comply with the mesh IFU

  4. Subject required more than a single piece of mesh

  5. Subject has a surgical wound classified as Class II (clean-contaminated), Class III (contaminated) or Class IV (dirty/infected) as defined by the CDC classification

  6. Subject with an American Society of Anesthesiologists (ASA) score of Class 4, 5, or 6

  7. Inability to close the hernia defect

  8. Subject's procedure required a multi-stage repair

  9. Subject's minimally invasive procedure required to convert to open

Study Design

Total Participants: 110
Treatment Group(s): 1
Primary Treatment: MaxTack™ Motorized Fixation Device
Phase:
Study Start date:
November 26, 2024
Estimated Completion Date:
February 15, 2027

Study Description

A prospective, post-market, multicenter, nonrandomized, single-arm, interventional clinical study of the MaxTack™ Motorized Fixation Device when used for fixation of prosthetic material to soft tissue in minimally invasive ventral hernia repair procedures in the short (1, 3 months) and long term (12 months).

110 male or female subjects will be enrolled in approximately 10 USA sites in subjects who are undergoing elective ventral hernia repair (primary or incisional).

Connect with a study center

  • The Ohio State University

    Columbus, Ohio 43210
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.